Market Cap 37.75M
Revenue (ttm) 50,000.00
Net Income (ttm) -45.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -91,860.00%
Debt to Equity Ratio 0.00
Volume 312,600
Avg Vol 385,154
Day's Range N/A - N/A
Shares Out 26.59M
Stochastic %K 44%
Beta 1.03
Analysts Strong Sell
Price Target $7.00

Company Profile

INmune Bio Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, which is in Phase II for the treatment of br...

Industry: Biotechnology
Sector: Healthcare
Phone: 561-710-0512
Address:
225 NE Mizner Blvd., Suite 640, Boca Raton, United States
NachoBusiness
NachoBusiness Jun. 3 at 5:30 PM
$INMB only company that drops every PR
0 · Reply
NachoBusiness
NachoBusiness Jun. 3 at 1:46 PM
$INMB well done Mr. CEO
0 · Reply
LibertarianTreehugger
LibertarianTreehugger Jun. 3 at 12:45 AM
INmune Bio Reports Positive MRI Findings in Phase 2 Alzheimer's Study: https://jlsfund.substack.com/p/inmune-bio-reports-positive-mri-findings $INMB
1 · Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX Jun. 2 at 6:40 PM
$INMB Another great Steve call
1 · Reply
NachoBusiness
NachoBusiness Jun. 2 at 3:15 PM
$INMB looks like retail is about to get dumped on again
0 · Reply
TW_Research
TW_Research Jun. 2 at 1:57 PM
$INMB More evidence of target engagement from Xpro. Myelin repair is a big deal in AD and an even bigger deal in many other diseases such as MS. https://twresearchgroup.com/2026/06/inmune-bio-reports-statistically-significant-treatment-effect-on-advanced-white-matter-mri-biomarker-in-phase-2-mindful-alzheimers-trial/
1 · Reply
bioinvestorrr
bioinvestorrr Jun. 2 at 1:26 PM
1 · Reply
DonCorleone77
DonCorleone77 Jun. 2 at 1:16 PM
$INMB INmune Bio reports positive MRI data in Phase 2 Alzheimer's trial INmune Bio announced positive results from exploratory MRI imaging analyses of its MINDFuL Phase 2 trial of XPro in patients with early Alzheimer's disease. "A statistically significant treatment effect on white matter across the full mITT population, strengthening further in inflammation-enriched patients, tells us that XPro is doing exactly what it is designed to do, with increased effect in patients we intend to treat in the registrational study," said David Moss, CEO of INmune Bio. INmune Bio plans to present the complete dataset at the Alzheimer's Association International Conference in July.
0 · Reply
Ganjaaroi
Ganjaaroi Jun. 2 at 12:22 PM
$INMB very
0 · Reply
NachoBusiness
NachoBusiness Jun. 2 at 12:10 PM
$INMB Low volume , $1.50 already sold off , bid back to 1.41 already. That lasted 15 seconds
0 · Reply
Latest News on INMB
INmune Bio Slides: Corporate presentation

Jun 2, 2026, 7:00 AM EDT - 2 days ago

INmune Bio Slides: Corporate presentation


INmune Bio publishes MINDFuL trial results in NPJ Dementia

2026-05-15T13:24:06.000Z - 20 days ago

INmune Bio publishes MINDFuL trial results in NPJ Dementia


INmune Bio receives fast track designation from FDA for XPro

2026-05-14T14:59:02.000Z - 21 days ago

INmune Bio receives fast track designation from FDA for XPro


INmune Bio Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 weeks ago

INmune Bio Earnings Call Transcript: Q1 2026


INmune Bio Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 weeks ago

INmune Bio Earnings release: Q1 2026


INmune Bio Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 weeks ago

INmune Bio Quarterly report: Q1 2026


INmune Bio Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 6 weeks ago

INmune Bio Proxy statement: Proxy filing


INmune Bio announces new preclinical data for INB03

2026-04-16T14:16:48.000Z - 7 weeks ago

INmune Bio announces new preclinical data for INB03


INmune Bio Earnings Call Transcript: Q4 2025

Mar 30, 2026, 4:30 PM EDT - 2 months ago

INmune Bio Earnings Call Transcript: Q4 2025


INmune Bio Annual report: Q4 2025

Mar 30, 2026, 4:30 PM EDT - 2 months ago

INmune Bio Annual report: Q4 2025


INmune Bio Earnings release: Q4 2025

Mar 30, 2026, 4:30 PM EDT - 2 months ago

INmune Bio Earnings release: Q4 2025


INmune Bio upgraded to Buy from Neutral at Lucid Capital

2026-03-11T10:11:18.000Z - 3 months ago

INmune Bio upgraded to Buy from Neutral at Lucid Capital


INmune Bio Slides: Corporate presentation

Mar 10, 2026, 7:00 AM EDT - 3 months ago

INmune Bio Slides: Corporate presentation


INmune Bio Transcript: Study update

Feb 26, 2026, 1:00 PM EST - 3 months ago

INmune Bio Transcript: Study update


INmune Bio publishes study on INmune’s CORDStrom platform

2025-12-05T12:10:33.000Z - 6 months ago

INmune Bio publishes study on INmune’s CORDStrom platform


INmune Bio reports Q3 EPS (24c), consensus (32c)

2025-10-30T20:46:45.000Z - 7 months ago

INmune Bio reports Q3 EPS (24c), consensus (32c)


INmune Bio Earnings Call Transcript: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 7 months ago

INmune Bio Earnings Call Transcript: Q3 2025


INmune Bio Earnings release: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 7 months ago

INmune Bio Earnings release: Q3 2025


INmune Bio Quarterly report: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 7 months ago

INmune Bio Quarterly report: Q3 2025


INmune Bio Proxy statement: Proxy Filing

Oct 14, 2025, 8:00 AM EDT - 8 months ago

INmune Bio Proxy statement: Proxy Filing


INmune Bio Proxy statement: Proxy Filing

Oct 3, 2025, 8:00 AM EDT - 8 months ago

INmune Bio Proxy statement: Proxy Filing


INmune Bio CEO RJ Tesi retires, David Moss succeeds

2025-08-07T21:55:30.000Z - 10 months ago

INmune Bio CEO RJ Tesi retires, David Moss succeeds


INmune Bio reports Q2 EPS ($1.05), consensus (38c)

2025-08-07T21:50:15.000Z - 10 months ago

INmune Bio reports Q2 EPS ($1.05), consensus (38c)


INmune Bio Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 10 months ago

INmune Bio Earnings Call Transcript: Q2 2025


INmune Bio Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 10 months ago

INmune Bio Earnings release: Q2 2025


INmune Bio Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 10 months ago

INmune Bio Quarterly report: Q2 2025


INmune Bio Slides: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 10 months ago

INmune Bio Slides: Q2 2025


INmune Bio Transcript: Status Update

Jun 30, 2025, 8:00 AM EDT - 1 year ago

INmune Bio Transcript: Status Update


INmune Bio Press release: Status Update

Jun 30, 2025, 8:00 AM EDT - 1 year ago

INmune Bio Press release: Status Update


INmune Bio Proxy statement: Proxy Filing

May 9, 2025, 8:00 AM EDT - 1 year ago

INmune Bio Proxy statement: Proxy Filing


INmune Bio Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

INmune Bio Earnings Call Transcript: Q1 2025


INmune Bio Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

INmune Bio Earnings release: Q1 2025


INmune Bio Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

INmune Bio Quarterly report: Q1 2025


INmune Bio Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

INmune Bio Proxy statement: Proxy Filing


INmune Bio Proxy statement: Proxy Filing

Apr 21, 2025, 8:00 AM EDT - 1 year ago

INmune Bio Proxy statement: Proxy Filing


INmune Bio Slides: Corporate Presentation

Apr 3, 2025, 7:00 AM EDT - 1 year ago

INmune Bio Slides: Corporate Presentation


INmune Bio Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

INmune Bio Earnings Call Transcript: Q4 2024


INmune Bio Earnings release: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

INmune Bio Earnings release: Q4 2024


INmune Bio Annual report: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

INmune Bio Annual report: Q4 2024


INmune Bio Transcript: Study Result

Feb 10, 2025, 8:30 AM EST - 1 year ago

INmune Bio Transcript: Study Result


INmune Bio Earnings Call Transcript: Q3 2024

Oct 31, 2024, 4:30 PM EDT - 1 year ago

INmune Bio Earnings Call Transcript: Q3 2024


INmune Bio Earnings release: Q3 2024

Oct 31, 2024, 4:30 PM EDT - 1 year ago

INmune Bio Earnings release: Q3 2024


INmune Bio Quarterly report: Q3 2024

Oct 31, 2024, 4:30 PM EDT - 1 year ago

INmune Bio Quarterly report: Q3 2024


INmune Bio Announces $13.0 Million Registered Direct Offering

Sep 13, 2024, 8:30 AM EDT - 1 year ago

INmune Bio Announces $13.0 Million Registered Direct Offering


INmune Bio Registration statement: Registration Filing

Aug 2, 2024, 8:00 AM EDT - 1 year ago

INmune Bio Registration statement: Registration Filing


INmune Bio Earnings Call Transcript: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

INmune Bio Earnings Call Transcript: Q2 2024


INmune Bio Quarterly report: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

INmune Bio Quarterly report: Q2 2024


INmune Bio Earnings release: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

INmune Bio Earnings release: Q2 2024


INmune Bio Inc. to Join Russell 3000® Index

May 30, 2024, 8:00 AM EDT - 2 years ago

INmune Bio Inc. to Join Russell 3000® Index


INmune Bio Proxy statement: Proxy Filing

May 29, 2024, 8:00 AM EDT - 2 years ago

INmune Bio Proxy statement: Proxy Filing


INmune Bio Earnings Call Transcript: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

INmune Bio Earnings Call Transcript: Q1 2024


INmune Bio Quarterly report: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

INmune Bio Quarterly report: Q1 2024


INmune Bio Earnings release: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

INmune Bio Earnings release: Q1 2024


INmune Bio Registration statement: Registration Filing

May 1, 2024, 8:00 AM EDT - 2 years ago

INmune Bio Registration statement: Registration Filing


NachoBusiness
NachoBusiness Jun. 3 at 5:30 PM
$INMB only company that drops every PR
0 · Reply
NachoBusiness
NachoBusiness Jun. 3 at 1:46 PM
$INMB well done Mr. CEO
0 · Reply
LibertarianTreehugger
LibertarianTreehugger Jun. 3 at 12:45 AM
INmune Bio Reports Positive MRI Findings in Phase 2 Alzheimer's Study: https://jlsfund.substack.com/p/inmune-bio-reports-positive-mri-findings $INMB
1 · Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX Jun. 2 at 6:40 PM
$INMB Another great Steve call
1 · Reply
NachoBusiness
NachoBusiness Jun. 2 at 3:15 PM
$INMB looks like retail is about to get dumped on again
0 · Reply
TW_Research
TW_Research Jun. 2 at 1:57 PM
$INMB More evidence of target engagement from Xpro. Myelin repair is a big deal in AD and an even bigger deal in many other diseases such as MS. https://twresearchgroup.com/2026/06/inmune-bio-reports-statistically-significant-treatment-effect-on-advanced-white-matter-mri-biomarker-in-phase-2-mindful-alzheimers-trial/
1 · Reply
bioinvestorrr
bioinvestorrr Jun. 2 at 1:26 PM
1 · Reply
DonCorleone77
DonCorleone77 Jun. 2 at 1:16 PM
$INMB INmune Bio reports positive MRI data in Phase 2 Alzheimer's trial INmune Bio announced positive results from exploratory MRI imaging analyses of its MINDFuL Phase 2 trial of XPro in patients with early Alzheimer's disease. "A statistically significant treatment effect on white matter across the full mITT population, strengthening further in inflammation-enriched patients, tells us that XPro is doing exactly what it is designed to do, with increased effect in patients we intend to treat in the registrational study," said David Moss, CEO of INmune Bio. INmune Bio plans to present the complete dataset at the Alzheimer's Association International Conference in July.
0 · Reply
Ganjaaroi
Ganjaaroi Jun. 2 at 12:22 PM
$INMB very
0 · Reply
NachoBusiness
NachoBusiness Jun. 2 at 12:10 PM
$INMB Low volume , $1.50 already sold off , bid back to 1.41 already. That lasted 15 seconds
0 · Reply
NachoBusiness
NachoBusiness Jun. 2 at 12:07 PM
$INMB INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial Let’s see if it actually runs
0 · Reply
CcBuyer
CcBuyer Jun. 2 at 1:28 AM
$INMB https://finance.yahoo.com/sectors/healthcare/articles/inmune-bio-inmb-q4-2025-211543411.html
0 · Reply
dachshund36
dachshund36 Jun. 1 at 4:49 PM
$INMB Does this look like someone is manipulating the price?
1 · Reply
NachoBusiness
NachoBusiness May. 29 at 2:23 PM
$INMB Down another 5%.. The inept CEO remains silent
0 · Reply
10baggerPete
10baggerPete May. 28 at 8:15 PM
$INMB maybe it's trash , maybe it's treasure. But with certainty it's annoying.
1 · Reply
SevenPhigs27
SevenPhigs27 May. 28 at 9:19 AM
$INMB One man's trash is another mans treasure.
1 · Reply
NachoBusiness
NachoBusiness May. 27 at 4:20 AM
$INMB trash is down to 1.35 overnight CEO fired yet?
0 · Reply
AIBioScanner
AIBioScanner May. 25 at 6:25 AM
$INMB AI-Based Findings on INMB After running INMB through my AI-driven quantitative framework, the stock is in a sideways/mixed trend with price trading near both moving averages with no clear directional pressure. INMB is trading around $1.45, near both the 20-day (~$1.46) and 50-day (~$1.35) moving averages — indicating indecision and softening structure. Key signals: • Trading near both MAs — sideways/mixed trend • MACD positive (0.03) — bullish momentum • Range between ~$1.24 support and ~$1.68 resistance 1-Month Outlook: Base scenario: consolidation near $1.38–$1.52 Breakout above $1.52 could open a move toward $1.78 Breakdown below $1.38 may extend further downside toward $1.13 Structure is neutral-to-mixed. Requires strong volume confirmation for any reversal. Not financial advice.
0 · Reply
All_just_a_game
All_just_a_game May. 21 at 3:36 PM
$ALT $ATNM $GALT $INMB Yep….almost a year gone by and still…. 💩
1 · Reply
NachoBusiness
NachoBusiness May. 19 at 1:44 PM
$INMB All the pumpers have disappeared and dropped their shares on retail as usual. The CEO is quiet, and the company is going OTC soon. This will end up just like their parent Company does and it’s a shame because the drug actually works
0 · Reply
zampy
zampy May. 18 at 11:37 PM
$INMB Reconstitution was April 30th INMB was under 150m mkt cap..on deletion list. On may 22nd this Friday you will see the additions on the deletions for the russell 2000. In this case deletion. On June 26th you will see ETF'S...that mirror Russell 2000 be forced to liquidate. Hope this helps asir.
3 · Reply
zampy
zampy May. 18 at 11:16 PM
$INMB Think this is out of the index and expect end of June 2.6m shares dump.
2 · Reply